2022 annual financial data
Palvella Therapeutics 2022 Operating margin
Palvella Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -167.84%.
Operating income was -43,474,000 USD and net income was -33,277,000 USD.
Operating cash flow was -14,840,000 USD.
Get free Palvella Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,902,000 USD
- Operating income
- -43,474,000 USD
- Net income
- -33,277,000 USD
- Operating cash flow
- -14,840,000 USD